• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性完全闭塞合并多支血管病变患者经皮冠状动脉介入治疗后残余 SYNTAX 评分的临床意义:与冠状动脉旁路移植术的比较。

Clinical implications of residual SYNTAX score after percutaneous coronary intervention in patients with chronic total occlusion and multivessel coronary artery disease: a comparison with coronary artery bypass grafting.

机构信息

Division of Cardiology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.

出版信息

EuroIntervention. 2017 May 15;13(1):97-105. doi: 10.4244/EIJ-D-16-00421.

DOI:10.4244/EIJ-D-16-00421
PMID:28242583
Abstract

AIMS

In this study we sought to evaluate the clinical impact of the residual SYNTAX score (rSS) after percutaneous coronary intervention (PCI) in patients with chronic total occlusion (CTO) and multivessel coronary artery disease (CAD).

METHODS AND RESULTS

We analysed data from 1,043 patients with CTO and multivessel CAD who were treated with PCI or coronary artery bypass grafting (CABG). Patients were divided into three groups: patients with rSS≤12 after PCI (rSS≤12 group, n=445), patients with rSS>12 after PCI (rSS>12 group, n=150), and patients who underwent CABG (CABG group, n=448). We compared the incidence of cardiac death among the three groups. During a median follow-up period of 42 months, cardiac death occurred in 14 patients (3.1%) in the rSS≤12 group, 14 patients (9.3%) in the rSS>12 group, and 29 patients (6.5%) in the CABG group. On multivariate analysis, the rSS≤12 group had a significantly lower incidence of cardiac death than the rSS>12 group (hazard ratio [HR] 0.35, 95% confidence interval [CI]: 0.16 to 0.75; p=0.01), but had an incidence of cardiac death similar to that of the CABG group (HR 0.63, 95% CI: 0.32 to 1.23; p=0.17).

CONCLUSIONS

An rSS≤12 after PCI may reduce the risk of cardiac mortality and could be a measure of reasonable incomplete revascularisation in patients with CTO and multivessel CAD.

摘要

目的

本研究旨在评估慢性完全闭塞(CTO)合并多支血管病变患者经皮冠状动脉介入治疗(PCI)后残余 SYNTAX 评分(rSS)的临床影响。

方法和结果

我们分析了 1043 例 CTO 合并多支血管病变患者的 PCI 或冠状动脉旁路移植术(CABG)治疗数据。患者分为三组:PCI 后 rSS≤12 的患者(rSS≤12 组,n=445)、PCI 后 rSS>12 的患者(rSS>12 组,n=150)和接受 CABG 的患者(CABG 组,n=448)。我们比较了三组患者的心脏死亡发生率。在中位数为 42 个月的随访期间,rSS≤12 组有 14 例(3.1%)、rSS>12 组有 14 例(9.3%)和 CABG 组有 29 例(6.5%)发生心脏死亡。多变量分析显示,rSS≤12 组的心脏死亡发生率明显低于 rSS>12 组(风险比[HR]0.35,95%置信区间[CI]:0.16 至 0.75;p=0.01),但与 CABG 组的心脏死亡发生率相似(HR 0.63,95%CI:0.32 至 1.23;p=0.17)。

结论

PCI 后 rSS≤12 可降低心脏死亡率风险,可能是 CTO 合并多支血管病变患者合理不完全血运重建的衡量标准。

相似文献

1
Clinical implications of residual SYNTAX score after percutaneous coronary intervention in patients with chronic total occlusion and multivessel coronary artery disease: a comparison with coronary artery bypass grafting.慢性完全闭塞合并多支血管病变患者经皮冠状动脉介入治疗后残余 SYNTAX 评分的临床意义:与冠状动脉旁路移植术的比较。
EuroIntervention. 2017 May 15;13(1):97-105. doi: 10.4244/EIJ-D-16-00421.
2
Second-generation drug-eluting stenting versus coronary artery bypass grafting for treatment of coronary chronic total occlusion.第二代药物洗脱支架与冠状动脉旁路移植术治疗冠状动脉慢性完全闭塞。
J Cardiol. 2019 May;73(5):432-437. doi: 10.1016/j.jjcc.2018.12.008. Epub 2019 Jan 2.
3
The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.残余SYNTAX评分对经皮冠状动脉介入治疗的多支冠状动脉疾病患者长期临床结局的增量影响。
Catheter Cardiovasc Interv. 2015 Jul;86(1):3-10. doi: 10.1002/ccd.25753. Epub 2015 Apr 9.
4
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).经皮冠状动脉介入治疗与冠状动脉旁路移植术在需要透析的终末期肾病患者中的比较(CREDO-Kyoto PCI/CABG 登记研究队列-2 的 5 年结果)。
Am J Cardiol. 2014 Aug 15;114(4):555-61. doi: 10.1016/j.amjcard.2014.05.034. Epub 2014 Jun 6.
5
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study.三血管病变或左主干病变患者完全血运重建后十年全因死亡情况:来自 SYNTAX 扩展生存研究的结果。
Circulation. 2021 Jul 13;144(2):96-109. doi: 10.1161/CIRCULATIONAHA.120.046289. Epub 2021 May 20.
6
Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion and Multivessel Disease.慢性全闭塞病变合并多支血管病变患者的冠状动脉旁路移植术和经皮冠状动脉介入治疗。
Circ Cardiovasc Interv. 2022 Feb;15(2):e011312. doi: 10.1161/CIRCINTERVENTIONS.121.011312. Epub 2022 Feb 15.
7
Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.在多支冠状动脉疾病中,与药物洗脱支架经皮介入治疗相比,多动脉血管移植术具有生存优势:一项倾向评分调整分析。
Int J Cardiol. 2015;189:153-8. doi: 10.1016/j.ijcard.2015.04.059. Epub 2015 Apr 9.
8
Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.经皮冠状动脉介入治疗后的合理不完全血运重建:SYNTAX 血运重建指数。
EuroIntervention. 2015 Oct;11(6):634-42. doi: 10.4244/EIJY14M10_05.
9
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.SYNTAX 试验中发生的卒中分析:冠状动脉旁路移植术与经皮冠状动脉介入治疗治疗复杂冠状动脉疾病的比较。
JACC Cardiovasc Interv. 2013 Apr;6(4):344-54. doi: 10.1016/j.jcin.2012.11.010. Epub 2013 Mar 20.
10
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.在紫杉醇药物涂层支架与心脏搭桥术联合治疗左主干病变研究中,经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗左主干病变患者的 5 年结果。
Circulation. 2014 Jun 10;129(23):2388-94. doi: 10.1161/CIRCULATIONAHA.113.006689. Epub 2014 Apr 3.

引用本文的文献

1
Progress in the Application of the Residual SYNTAX Score and Its Derived Scores.残余SYNTAX评分及其衍生评分的应用进展
Rev Cardiovasc Med. 2024 Mar 1;25(3):80. doi: 10.31083/j.rcm2503080. eCollection 2024 Mar.
2
A non-interventional cardiologist's guide to coronary chronic total occlusions.非介入心脏病专家的冠状动脉慢性完全闭塞指南。
Front Cardiovasc Med. 2024 Feb 6;11:1350549. doi: 10.3389/fcvm.2024.1350549. eCollection 2024.
3
Assessing the Clinical Influence of Chronic Total Occlusions (CTOs) Revascularization and the Impact of Vascularization Completeness on Patients with Left Ventricular (LV) Systolic Dysfunction.
评估慢性完全闭塞(CTO)血运重建的临床影响,以及血管化完全程度对左心室(LV)收缩功能障碍患者的影响。
Comput Intell Neurosci. 2022 Aug 10;2022:9128206. doi: 10.1155/2022/9128206. eCollection 2022.
4
Chronic total occlusion revascularization: A complex piece to "complete" the puzzle.慢性完全闭塞病变血管重建:“拼完”拼图的复杂一块。
World J Cardiol. 2022 Jan 26;14(1):13-28. doi: 10.4330/wjc.v14.i1.13.
5
Effects of coronary revascularization by elective percutaneous coronary intervention on cardiac autonomic modulation assessed by heart rate variability: a single-center prospective cohort study.通过心率变异性评估选择性经皮冠状动脉介入治疗进行冠状动脉血运重建对心脏自主神经调节的影响:一项单中心前瞻性队列研究。
Am J Cardiovasc Dis. 2021 Feb 15;11(1):164-175. eCollection 2021.